PR Newswire PHOENIX, May 13, 2025 Air Evac is setting the gold standard in Arizona, providing specialist emergency 'in-air' perinatal care to the communities of Arizona • Air Evac is Arizona's premier Neonatal Intensive Care Unit (NICU) transport team certified in Neonatal Pediatric ...
Read MorePR Newswire TAIPEI, May 14, 2025 TAIPEI, May 14, 2025 /PRNewswire/ -- Caliway Biopharmaceuticals (TWSE: 6919) today announced the successful End-of-Phase 2 (EOP2) meeting with the U.S. Food and Drug Administration (FDA) for CBL-514, the company's proprietary first-in-class injectable drug ...
Read MorePR Newswire LAS VEGAS, May 13, 2025 DelveInsight's analysis forecasts liver fibrosis market growth due to the introduction of emerging therapies, expecting an increase in market size during the study period (2020–2034). This anticipated growth is driven by advancements in treatment options, ...
Read MorePR Newswire ELGIN, Ill., May 13, 2025 ELGIN, Ill., May 13, 2025 /PRNewswire/ -- Footprints to Recovery, a leading provider of addiction and mental health services, is pleased to announce the launch of its new, private inpatient mental health treatment program at its Elgin, Illinois ...
Read MorePR Newswire HENDERSON, Nev., May 13, 2025 FDA has approved an aggressive stem cell clinical trial, offering potential new relief through intravenous (IV) administration. HENDERSON, Nev., May 13, 2025 /PRNewswire-PRWeb/ -- "We at L2 Bio thank the FDA for what we believe is a very ...
Read MorePR Newswire LONDON, May 14, 2025 LONDON, May 14, 2025 /PRNewswire/ -- Kaerus Bioscience ("Kaerus" or "the Company"), a clinical stage biopharmaceutical company created by Medicxi for the development of therapeutics for rare genetic syndromes of neurodevelopment, today announces that its ...
Read MorePR Newswire NASHVILLE, Tenn. and CAMBRIDGE, England, May 13, 2025 Cumberland leveraging Qureight's deep-learning AI platform for its Phase II FIGHTING FIBROSIS™ clinical trial NASHVILLE, Tenn. and CAMBRIDGE, England, May 13, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: ...
Read MorePR Newswire KYOTO, Japan, May 14, 2025 KYOTO, Japan, May 14, 2025 /PRNewswire/ -- Joint study by University of Shizuoka, Kobe University, and Noster Inc. uncovers a novel postbiotic pathway for obesity prevention. A new collaborative study from the University of Shizuoka, Kobe ...
Read MorePR Newswire PHILADELPHIA, May 14, 2025 PHILADELPHIA , May 14, 2025 /PRNewswire/ -- A new survey of 2,000 Americans by TENA, a leading incontinence brand, highlights the daily struggles of those living with UI – from how it impacts their emotional well-being and daily live to their biggest ...
Read MoreSubscribe to our Free Newsletters!
Medindia's policies are aligned with the United Nations Sustainable Development Goals (SDGs) - SDG 3, SDG 4, SDG 5, SDG 6 , SDG 10 & SDG 12.
Disclaimer - All information and content on this site are provided for informational and educational purposes only. They should NOT be used for the diagnosis or treatment of any health-related condition or disease. Always consult a qualified healthcare professional for medical advice, diagnosis, or treatment. Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2025
Careers